MKLN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.76205749780456E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.85449999801079E-09 |
Normal-vs-Stage2 |
2.02219999999587E-05 |
Normal-vs-Stage3 |
2.33146835171283E-15 |
Normal-vs-Stage4 |
5.58020296637096E-12 |
Stage1-vs-Stage2 |
7.727800E-01 |
Stage1-vs-Stage3 |
6.553500E-04 |
Stage1-vs-Stage4 |
1.497770E-02 |
Stage2-vs-Stage3 |
7.407700E-02 |
Stage2-vs-Stage4 |
1.694590E-01 |
Stage3-vs-Stage4 |
6.019600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.79043455009287E-12 |
Normal-vs-AfricanAmerican |
1.50113255159567E-12 |
Normal-vs-Asian |
9.432000E-02 |
Caucasian-vs-AfricanAmerican |
1.390100E-02 |
Caucasian-vs-Asian |
3.953400E-01 |
AfricanAmerican-vs-Asian |
4.570200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.06421554796543E-14 |
Normal-vs-Female |
8.03920041647643E-10 |
Male-vs-Female |
3.550600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.06979999999702E-05 |
Normal-vs-Age(41-60Yrs) |
7.7335999826289E-09 |
Normal-vs-Age(61-80Yrs) |
1.6251444634463E-12 |
Normal-vs-Age(81-100Yrs) |
5.00810000025886E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.985000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.757400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.892800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.860500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.386970E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.417000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.289500E-02 |
Normal-vs-Grade 2 |
1.35950000035301E-07 |
Normal-vs-Grade 3 |
9.43467526326458E-13 |
Normal-vs-Grade 4 |
1.64956936998806E-12 |
Grade 1-vs-Grade 2 |
4.871800E-01 |
Grade 1-vs-Grade 3 |
3.499900E-02 |
Grade 1-vs-Grade 4 |
5.837700E-03 |
Grade 2-vs-Grade 3 |
3.535500E-03 |
Grade 2-vs-Grade 4 |
7.84409999999847E-05 |
Grade 3-vs-Grade 4 |
4.775800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.78709999998361E-06 |
Normal-vs-ccB subtype |
1.90336635341737E-12 |
ccA subtype-vs-ccB subtype |
4.392500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.57559554081877E-11 |
Normal-vs-N1 |
5.68570000000213E-05 |
N0-vs-N1 |
2.740600E-01 |
|
|